Gala vs PeterMD: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

49 providers verified independently·Independent research·How we rank →

PeterMD beats Gala overall, scoring 7.3/10 vs 7.2/10. Gala is more affordable at $149/mo vs $165/mo. Choose Gala for tirzepatide-first patients who want a low-cost compounded pa. Choose PeterMD for budget-conscious users looking for the lowest monthly glp-1 .

A side-by-side comparison of Gala and PeterMD covering pricing, scores, medication types, insurance, and more to help you decide.

Gala

#40 of 49

7.2/10

Telehealth platform focused on compounded tirzepatide — both microdose and full-dose tiers — alongside a brand-name semaglutide (Ozempic) path and a 'coming soon' Wegovy pill. Operated by AI Coaching, Inc. (Wilmington, DE), backed by OpenLoop-affiliated medical groups (a recognized US telehealth backend) and LegitScript verified. Differentiator: a dedicated 'Gala GLP-1 Tracker' iOS + Android app for in-treatment dosing, weight, and side-effect logging.

Visit Gala

Higher Rated

PeterMD

#33 of 49

7.3/10

One of the most affordable compounded GLP-1 options on the market, ideal for budget-conscious patients.

Visit PeterMD

Feature	Gala	PeterMD
Our Score	7.2/10	7.3/10
Starting Price	$149/mo	$165/mo
Medication Type	Both	Compounded
Insurance Accepted	No	No
Best For	Tirzepatide-first patients who want a low-cost compounded path (microdose $149/mo or full-dose $179-199/mo) plus a dedicated iOS + Android tracker app for daily progress logging	Budget-conscious users looking for the lowest monthly GLP-1 cost
Ranking	#40	#33

Pros & Cons Compared

Gala

Pros

+Microdose compounded tirzepatide at $149/mo — the cheapest microdose tirz on a tracked telehealth platform; full-dose compounded tirzepatide at $179/mo (yearly plan) or $199/mo (3-month plan)
+Dedicated 'Gala GLP-1 Tracker' on BOTH iOS and Android — first-party in-treatment logging is uncommon among compounded-only platforms
+OpenLoop-affiliated medical groups + LegitScript verification provide third-party accountability that many compounded-only platforms lack
+All 50 states, free shipping, no insurance required, 24/7 patient support claimed

Cons

−Brand-name Ozempic pricing ($1,299/mo) is materially above market — NovoCare direct pricing for Wegovy is $349/mo, Hers offers Wegovy at $149/mo via the 2026 Novo Nordisk partnership
−Tirzepatide-only on the compounded side — compounded semaglutide is NOT offered, narrower medication menu than peers like Maximus, Ro, or Henry Meds
−Mixed Trustpilot reviews mention dosing inconsistencies and slow customer service responsiveness — verify your specific dose and batch with each refill
−Initial consultation typically a sync video visit, but ongoing follow-ups and questions are chat-based (no scheduled ongoing video access) — and no published labs, no named medical director, no specialty obesity oversight
−Restrictive refund policy — Gala's published terms state 'IN NO EVENT SHALL YOU BE ISSUED A REFUND UPON CANCELLATION OF THE SUBSCRIPTION SERVICES' with a narrow exception for provider-initiated medical disqualification. No money-back guarantee. Read the published policy at galaglp1.com/refund-policy before enrolling on a commitment plan
−Newer brand under AI Coaching, Inc. (founded 2024 per LinkedIn) — limited public company history; founders, founding year, and named medical director not publicly disclosed on galaglp1.com itself

PeterMD

Pros

+Flat $165/mo at all dose levels — price doesn't increase as you titrate up to maintenance doses
+Semaglutide + B12 formulation helps reduce nausea — the most common GLP-1 side effect
+100,000+ patient base with 4.9/5 Trustpilot rating from 14,000+ reviews — strong social proof
+Video consultations with physicians included — real face-to-face medical oversight

Cons

−Only available in 42 states — excluded from 8 states, limiting nationwide access
−Not BBB accredited, with some documented complaints about delayed medication fulfillment
−Originally a testosterone replacement therapy platform — GLP-1 is an expansion, not the core focus

Our Verdict

PeterMD edges out Gala with a score of 7.3/10 vs 7.2/10. If budget is your priority, Gala starts at $149/mo compared to PeterMD's $165/mo. Gala offers both brand-name and compounded medications, giving you more flexibility. Choose Gala if you want: tirzepatide-first patients who want a low-cost compounded path (microdose $149/mo or full-dose $179-199/mo) plus a dedicated ios + android tracker app for daily progress logging. Choose PeterMD if you want: budget-conscious users looking for the lowest monthly glp-1 cost.

Still undecided? Editor's #1 Overall Pick

Embody

$299/mo · 7.3/10 · Compounded

If neither Gala nor PeterMD feels like the right fit, our overall #1 pick across all 49 GLP-1 telehealth providers is Embody — strongest balance of clinical oversight, transparent pricing, and verified availability.

Visit Embody→Read our full Embody review